SUN PHARMACEUTICAL INDUSTRIES LTD. - Updates
Download 
|
< Back |
| 26 May 2016 | |
| Sun Pharmaceutical Industries Ltd has informed BSE that the Parties have terminated the Umbrella Agreement as well as the Transaction Agreements executed between Daiichi Sankyo Company Limited., Daiichi Sankyo (Thailand) Ltd. Ranbaxy, Ranbaxy (Netherlands) B.V., Ranbaxy UNICHEM Company Ltd., Ranbaxy (Thailand) Company Ltd. due to divestment of Ranbaxy by Daiichi Sankyo Company Limited.<BR><BR>Daiichi Sankyo Company Limited., Daiichi Sankyo (Thailand) Ltd., Sun Pharmaceutical Industries Ltd., Ranbaxy (Netherlands) B.V. and Ranbaxy (Thailand) Company Ltd. entered into a Termination Agreement on May 26, 2016 and agreed that the Umbrella Agreement as well as the executed Transaction Agreements will be terminated with effect as of the closing date, subject to the condition precedent of the occurrence of certain closing conditions as mutually agreed between the Parties.<BR><BR>Further, there is no material impact of such termination on either standalone or consolidated operations/ financial operations of our Company. Additionally, the said termination agreement does not apply to, or have an impact upon, other business relationship that the Parties to the said termination agreement may have in force. | |
| View all announcements for SUN PHARMACEUTICAL INDUSTRIES LTD. | Source: BSE India |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback